Intermittent Chemotherapy and Erlotinib for Nonsmokers or Light Smokers with Advanced Adenocarcinoma of the Lung: A Phase II Clinical Trial
Figure 1
A woman, 39, never-smoker, developed adenocarcinoma of the right lower lobe, T4 N2 M1b with metastases in bone and liver. 18F-FDG PET-CT before treatment (a) and after 4 months (b). Complete remission was confirmed also a year later.
